Clinical trials
Phase 4 Wound Infection trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 5 |
| Terminated | 2 |
| Withdrawn | 1 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Georgetown University | 2 |
| Odense University Hospital | 2 |
| Aultman Health Foundation | 1 |
| Bayside Health | 1 |
| Brigham and Women's Hospital | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Englewood Hospital and Medical Center | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Hacettepe University | 1 |
| Hamad General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wound Infection | 33 |
| Surgical Wound Infection | 9 |
| Infections | 3 |
| Wounds and Injuries | 3 |
| Burns | 2 |
| Fractures, Open | 2 |
| Hemorrhage | 2 |
| Obesity | 2 |
| Pain | 2 |
| Surgical Wound Dehiscence | 2 |
Trials
Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.